Inventor
MEYER EVERETT HURTEAU
US12 patents
⚠️ This page may combine multiple inventors who share the name “MEYER EVERETT HURTEAU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GIGAGEN INC
6 patentsUS9695474B2Jul 4, 2017
System and methods for massively parallel analysis of nucleic acids in single cells
GIGAGEN INC8 citations83
US11053543B2Jul 6, 2021
System and methods for massively parallel analysis of nucleic acids in single cells
GIGAGEN INC1 citations72
US10787706B2Sep 29, 2020
System and methods for massively parallel analysis of nucleic acids in single cells
GIGAGEN INC1 citations72
US10465243B2Nov 5, 2019
System and methods for massively parallel analysis of nucleic acids in single cells
GIGAGEN INC1 citations72
US11591652B2Feb 28, 2023
System and methods for massively parallel analysis of nucleic acids in single cells
GIGAGEN INC0 citations61
US10106789B2Oct 23, 2018
System and methods for massively parallel analysis of nucleic acids in single cells
GIGAGEN INC1 citations61
UNIV LELAND STANFORD JUNIOR
5 patentsUS7682614B2Mar 23, 2010
Methods for inhibition of NKT cells
UNIV LELAND STANFORD JUNIOR13 citations83
US11447747B2Sep 20, 2022
Methods for allogenic hematopoietic stem cell transplantation
UNIV LELAND STANFORD JUNIOR2 citations65
US10093734B2Oct 9, 2018
Blockade of RGMb for reducing transplantation-associated immune responses
UNIV LELAND STANFORD JUNIOR3 citations64
US11246890B2Feb 15, 2022
Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases
UNIV LELAND STANFORD JUNIOR2 citations62
US10669335B2Jun 2, 2020
Blockade of RGMB for reducing transplantation-associated inflammation leading to loss of function of a transplanted organ in a graft recipient
UNIV LELAND STANFORD JUNIOR0 citations44